Novel 7-chloro-(4-thioalkylquinoline) derivatives: synthesis and antiproliferative activity through inducing apoptosis and DNA/RNA damage
A series of 78 synthetic 7-chloro-(4-thioalkylquinoline) derivatives were investigated for cytotoxic activity against eight human cancer as well as 4 non-tumor cell lines. The results showed, with some exceptions, that sulfanyl 5–40 and sulfinyl 41–62 derivatives exhibited lower cytotoxicity for cancer cell lines than those of well-described sulfonyl N-oxide derivatives 63–82. As for compound 81, the most pronounced selectivity (compared against BJ and MRC-5 cells) was observed for human cancer cells from HCT116 (human colorectal cancer with wild-type p53) and HCT116p53−/− (human colorectal cancer with deleted p53), as well as leukemia cell lines (CCRF-CEM, CEM-DNR, K562, and K562-TAX), lung (A549), and osteosarcoma cells (U2OS). A good selectivity was also detected for compounds 73 and 74 for leukemic and colorectal (with and without p53 deletion) cancer cells (compared to MRC-5). At higher concentrations (5 × IC50) against the CCRF-CEM cancer cell line, we observe the accumulation of the cells in the G0/G1 cell phase, inhibition of DNA and RNA synthesis, and induction of apoptosis. In addition, X-ray data for com?pound 15 is being reported. These results provide useful scientific data for the development of 4-thioalkylquinoline derivatives as a new class of anticancer candidates.
History
Publication
Pharmaceuticals 2022, 15, 1234Publisher
MDPIOther Funding information
The project was partially funded by the France-Venezuela PCP program No. 2013000438, as well as the University of Bordeaux, the Centre National de la Recherche Scientifique (CNRS), the Czech Ministry of Education, Youth and Sports (CZ-OPENSCREEN-LM2018130, and EATRIS-CZ-LM2018133), and Escuela de Medicina UEES, 2022-MED-001 for financial support.Sustainable development goals
- (3) Good Health and Well-being
External identifier
Department or School
- Chemical Sciences